- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/00 - Drugs for genital or sexual disordersContraceptives
Patent holdings for IPC class A61P 15/00
Total number of patents in this class: 1921
10-year publication summary
|
59
|
85
|
134
|
141
|
144
|
155
|
143
|
147
|
134
|
79
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2709 |
26 |
| Abbvie Inc. | 1801 |
24 |
| Daiichi Sankyo Company, Limited | 1874 |
24 |
| Bayer Pharma AG | 1047 |
22 |
| Kissei Pharmaceutical Co., Ltd. | 184 |
16 |
| Bayer Schering Pharma AG | 385 |
15 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
14 |
| Osaka University | 3374 |
14 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 646 |
13 |
| Shionogi & Co., Ltd. | 853 |
13 |
| The Regents of the University of California | 19929 |
11 |
| Sunshine Lake Pharma Co., Ltd. | 599 |
11 |
| Boehringer Ingelheim International GmbH | 4648 |
10 |
| Janssen Pharmaceutica N.V. | 3383 |
10 |
| Ono Pharmaceutical Co., Ltd. | 434 |
10 |
| F. Hoffmann-La Roche AG | 7921 |
9 |
| Pfizer Inc. | 3381 |
9 |
| Bayer AG | 3331 |
9 |
| Eisai R&D Management Co., Ltd. | 1231 |
9 |
| ObsEva S.A. | 61 |
8 |
| Other owners | 1644 |